Regulatory issues

The FDA Needs to Enforce the Gluten-Free Labeling Rule

by Admin | Jan 29, 2018 | Advocacy, Gluten-free labeling, Gluten-free manufacturer, Regulatory issues, Restaurants | 2 |

By • Jennifer Iscol • Comment now on the Citizen Petition to the FDA “[W]ithout prompt and...

FDA proposal on gluten in drugs is inadequate

by Admin | Jan 28, 2018 | Advocacy, Celiac disease, Gluten in medication, Gluten sensitivity, Gluten-free labeling, Health, Regulatory issues | 0 |

By • Jennifer Iscol • Submit a comment to the FDA today Celiac disease advocates have been asking...

Special Report: Arsenic in Rice

by Admin | Mar 1, 2017 | Arsenic in rice, Children, Gluten-free diet, Regulatory issues | 0 |

Three-Part Series What did you eat on your gluten-free diet today? A bagel, pancakes or toast for...

Gluten in Medication: Pressing the FDA to Act Now

by Admin | Jan 13, 2016 | Advocacy, Children, Gluten in medication, Health, Regulatory issues | 0 |

Update on 12/14/17: FDA issued draft industry guidance yesterday titled “Gluten in Drug Products...

Gluten in Medication: Letter to the FDA from Michael Weber, December 2015

by Admin | Jan 7, 2016 | Gluten in medication, Health, Regulatory issues | 0 |

New York resident Michael Weber submitted a Citizen Petition to the FDA in June 2008 asking the FDA to either ban wheat gluten from drugs or require labeling. Following a March 2015 lawsuit by Public Citizen regarding the FDA’s...

Category: Regulatory issues

The FDA Needs to Enforce the Gluten-Free Labeling Rule

FDA proposal on gluten in drugs is inadequate

Special Report: Arsenic in Rice

Gluten in Medication: Pressing the FDA to Act Now

Gluten in Medication: Letter to the FDA from Michael Weber, December 2015

Join our list

You have Successfully Subscribed!

Support Us!

Categories

Sponsors